Published in Am J Physiol Renal Physiol on November 30, 2011
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis (2015) 0.78
The emerging role of coagulation proteases in kidney disease. Nat Rev Nephrol (2015) 0.76
The involvement of endothelial mediators in leprosy. Mem Inst Oswaldo Cruz (2016) 0.75
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 27.85
Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med (2006) 5.49
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med (2007) 3.35
The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int (2007) 2.57
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes (2000) 2.41
Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol (2010) 1.68
Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther (2010) 1.60
Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med (2009) 1.53
ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol (1996) 1.45
Role of inflammation in diabetic nephropathy. Curr Diabetes Rev (2008) 1.41
T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur J Immunol (1998) 1.39
MALA-2, mouse homologue of human adhesion molecule ICAM-1 (CD54). Eur J Immunol (1989) 1.37
Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol (2009) 1.36
Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev (2007) 1.27
The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol (2004) 1.20
A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. Blood (2001) 1.19
Immunosurveillance modelled in vitro: naive and memory T cells spontaneously migrate across unstimulated microvascular endothelium. Int Immunol (1997) 1.17
Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J Vasc Res (2006) 1.17
Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood (1991) 1.10
Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol (2009) 1.10
Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int (2002) 1.09
Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant (2010) 1.08
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens Res (2010) 1.08
Chronic kidney disease induced in mice by reversible unilateral ureteral obstruction is dependent on genetic background. Am J Physiol Renal Physiol (2010) 1.06
COMP-angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney Int (2009) 1.05
Mouse models of thrombosis: thrombomodulin. Thromb Haemost (2004) 1.00
F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int (2000) 0.99
Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol (2010) 0.99
Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation. Physiol Genomics (2007) 0.96
Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol (2009) 0.96
Novel mechanisms of endothelial dysfunction in diabetes. J Cardiovasc Dis Res (2010) 0.95
Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead. J Clin Hypertens (Greenwich) (2009) 0.92
Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum (1994) 0.91
Anti-inflammatory properties of drugs acting on the renin-angiotensin system. Drugs Today (Barc) (2005) 0.87
Pro-inflammatory angiogenesis is mediated by p38 MAP kinase. J Cell Physiol (2011) 0.87
Pentoxifylline prevents tumor necrosis factor-induced suppression of endothelial cell surface thrombomodulin. Thromb Res (1991) 0.86
Chronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells. J Immunol (2001) 0.84
Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Nephrol Dial Transplant (2007) 0.84
Renal tubular fluid shear stress promotes endothelial cell activation. Biochem Biophys Res Commun (2011) 0.83
Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications. Fundam Clin Pharmacol (2008) 0.83
Expression and localization of angiogenin in placenta: enhanced levels at term over first trimester villi. Mol Reprod Dev (2002) 0.82
[The expression and significance of the angiopoietin-1 in the kidney of diabetic rats]. Sichuan Da Xue Xue Bao Yi Xue Ban (2007) 0.81
Quantification and modulation of thrombomodulin activity in isolated rat and human glomeruli. Kidney Int (1992) 0.79
The angiopoietin/Tie-2 axis: a novel player in chronic kidney disease. Minerva Urol Nefrol (2010) 0.77
Negative regulatory role of PI3-kinase in TNF-induced tumor necrosis. Int J Cancer (2003) 0.77
Histopathologic findings and classification of feline renal transplants. Vet Pathol (2004) 0.77
A branched DNA signal amplification assay to quantitate messenger RNA of human uncoupling proteins 1, 2, and 3. Anal Biochem (2000) 0.76
FGF-21 as a novel metabolic regulator. J Clin Invest (2005) 10.69
Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem (2004) 4.40
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature (2008) 3.48
Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med (2007) 3.35
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19
Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes (2006) 3.02
Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR- independent mechanism involving Egr-1/Erk-1/2 activation. Arterioscler Thromb Vasc Biol (2007) 2.44
Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol (2002) 1.99
Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int (2004) 1.90
Flipped classroom model improves graduate student performance in cardiovascular, respiratory, and renal physiology. Adv Physiol Educ (2013) 1.88
VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res (2003) 1.82
Scaling up diarrhea prevention and treatment interventions: a Lives Saved Tool analysis. PLoS Med (2011) 1.72
Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol (2010) 1.68
Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit Care Med (2004) 1.57
Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol (2007) 1.57
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med (2002) 1.54
Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol (2007) 1.46
p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J (2002) 1.46
Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway. FASEB J (2009) 1.45
VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol (2008) 1.41
Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes (2002) 1.39
NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. J Biol Chem (2002) 1.35
IFATS collection: Adipose stromal cell differentiation is reduced by endothelial cell contact and paracrine communication: role of canonical Wnt signaling. Stem Cells (2008) 1.32
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest (2007) 1.32
Transforming growth factor-beta in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury. Am J Physiol Renal Physiol (2004) 1.26
New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). Crit Care (2005) 1.24
Circulating vascular progenitor cells do not contribute to compensatory lung growth. Circ Res (2003) 1.21
Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. Am J Physiol Heart Circ Physiol (2002) 1.20
Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2009) 1.19
Role of protein C in renal dysfunction after polymicrobial sepsis. J Am Soc Nephrol (2007) 1.18
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS One (2012) 1.18
Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J Vasc Res (2006) 1.17
Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood (2011) 1.17
Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res (2006) 1.17
Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J Clin Invest (2014) 1.16
The p53 inhibitor pifithrin-α can stimulate fibrosis in a rat model of ischemic acute kidney injury. Am J Physiol Renal Physiol (2011) 1.16
Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol (2008) 1.15
Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am J Physiol Renal Physiol (2007) 1.14
Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp Hematol (2008) 1.13
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells. Am J Pathol (2003) 1.12
Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol (2009) 1.10
Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med (2004) 1.09
Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med (2002) 1.08
FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis. Endocrinology (2012) 1.05
Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc Natl Acad Sci U S A (2003) 1.05
Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice. PLoS One (2012) 1.02
Activated protein C and acute kidney injury: Selective targeting of PAR-1. Curr Drug Targets (2009) 1.01
Role of complement activation in obliterative bronchiolitis post-lung transplantation. J Immunol (2013) 1.01
Small-molecule inhibition of the uPAR·uPA interaction: synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis. Bioorg Med Chem (2013) 1.00
Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression. Cancer Invest (2010) 1.00
Polymeric coatings that mimic the endothelium: combining nitric oxide release with surface-bound active thrombomodulin and heparin. Biomaterials (2007) 1.00
Distinct functions of activated protein C differentially attenuate acute kidney injury. J Am Soc Nephrol (2008) 0.99
Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am J Physiol Renal Physiol (2008) 0.98
MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury. Am J Physiol Renal Physiol (2011) 0.97
Live-animal imaging of renal function by multiphoton microscopy. Curr Protoc Cytom (2007) 0.96
Renal endothelial dysfunction in acute kidney ischemia reperfusion injury. Cardiovasc Hematol Disord Drug Targets (2014) 0.96
Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11. J Biol Chem (2007) 0.96
Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation. Physiol Genomics (2007) 0.96
Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol (2012) 0.96
A novel system for the reconstruction of a coronary artery lumen profile in real time: a preclinical validation. Am J Physiol Heart Circ Physiol (2009) 0.95
FBL2 regulates amyloid precursor protein (APP) metabolism by promoting ubiquitination-dependent APP degradation and inhibition of APP endocytosis. J Neurosci (2012) 0.95
Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction. Cardiovasc Diabetol (2005) 0.94
Increased ANG II sensitivity following recovery from acute kidney injury: role of oxidant stress in skeletal muscle resistance arteries. Am J Physiol Regul Integr Comp Physiol (2010) 0.94
NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo. PLoS One (2012) 0.94
Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (2013) 0.92
Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues. J Histochem Cytochem (2006) 0.92
Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp Hematol (2006) 0.92
Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study. Crit Care (2010) 0.92
Liver X receptor is a therapeutic target in collagen-induced arthritis. Arthritis Rheum (2007) 0.91
Expression levels of protein kinase C-alpha in non-small-cell lung cancer. Clin Lung Cancer (2004) 0.91
Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis. PLoS One (2013) 0.91
Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis. Exp Cell Res (2006) 0.91
Anti-inflammatory treatment with pentoxifylline improves HIV-related endothelial dysfunction: a pilot study. AIDS (2010) 0.90
Activated protein C and sepsis. Front Biosci (2006) 0.89
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas. Neuropharmacology (2008) 0.89
Bigendothelin-1 (1-21) fragment during early sepsis modulates tau, p38-MAPK phosphorylation and nitric oxide synthase activation. Mol Cell Biochem (2005) 0.88
Hybrid embryonic stem cell-derived tetraploid mice show apparently normal morphological, physiological, and neurological characteristics. Mol Cell Biol (2003) 0.88
Regulation of EMAP II by hypoxia. Am J Pathol (2003) 0.88
Pro-inflammatory angiogenesis is mediated by p38 MAP kinase. J Cell Physiol (2011) 0.87
Expression of the RNA-stabilizing protein HuR in ischemia-reperfusion injury of rat kidney. Am J Physiol Renal Physiol (2009) 0.86
Down-regulation of fragile histidine triad expression in prostate carcinoma. Cancer (2003) 0.86
Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer. Am J Transl Res (2012) 0.86
Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants. Int J Cancer (2004) 0.86
Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis. J Med Chem (2011) 0.85
Cardiac diastolic dysfunction in conscious dogs with heart failure induced by chronic coronary microembolization. Am J Physiol Heart Circ Physiol (2006) 0.84
NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells. Brain Res Mol Brain Res (2005) 0.84